The type 2 diabetes drug Januvia (generic: sitagliptin) may cause irreversible cases of pancreatic cancer, which could result in the death of the patient. Individuals taking Januvia should be aware of these serious risks, and consult their physicians immediately if adverse side effects begin to appear. Signs and symptoms of end-stage Januvia-induced pancreatic cancer may include pain in the abdomen or back, weight loss, bloating, nausea and jaundice.
Free Januvia Death Lawsuit Evaluation: If your loved one died from pancreatic cancer or thyroid cancer after taking Januvia, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Januvia and we can help.
What’s the Problem with Januvia?
Pancreatic cancer is one of the most deadly forms of the disease, and is a leading cause of cancer death for both men and women in the United States. In 2012 alone, approximately 45,000 Americans will be diagnosed with pancreatic cancer, and about 38,000 will die from it. Unfortunately, the diabetes drugs Januvia and Janumet may cause an increased risk of fatal pancreatic cancer. If you have lost a loved one from pancreatic cancer, or have suffered from acute pancreatitis, hemorrhagic pancreatitis, or necrotizing pancreatitis after taking Januvia, you should report these adverse reactions to the prescribing doctor as soon as possible.
Why is Pancreatic Cancer so Deadly?
The pancreas secretes hormones and enzymes to digest fats. One of these hormones is insulin, whose main function it is to prompt the body to use sugar in the blood rather than fat as energy. Its levels are low in diabetics, who suffer from abnormally high blood sugar.
According to the American Cancer Society, only about 20% of patients diagnosed with pancreatic cancer survive for a full year after diagnosis. The disease is particularly problematic because of its elusiveness – it develops rapidly, is extremely aggressive, and kills quickly. Pancreatic cancer is currently the fourth leading cause of cancer death in the United States.
In the vast majority of cases, pancreatic cancer isn’t diagnosed until late in the course of the disease because it doesn’t cause symptoms until it’s too late. Symptoms such as weight loss, abdominal pain, and jaundice usually begin manifesting themselves after the tumor has reached a significant size. By then, chances are that it has metastasized and spread to other parts of the body.
It has been estimated that less than 15% of cases of pancreatic cancer are diagnosed early enough to where surgery can be considered a realistic option. Making matters worse, the long-term outlook is bleak even in patients who do have the surgery, because it comes back about 85% of the time. Only 25 to 30% of patients are alive just five years after surgery. When most patients ultimately die of pancreatic cancer, they succumb due to liver failure from their liver being taken over by the tumor.
Januvia Sudden Death Study
According to a post-marketing study of sudden death among Januvia users, at least 12,389 individuals reported side effects after taking the drug. Among them, 138 people experienced sudden death. Shockingly, more than half of these patients died less than one month after initiating treatment with Januvia.
Do You Have a Januvia Death Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Januvia lawsuits. We are handling individual litigation nationwide and currently accepting new Januvia pancreatic cancer and thyroid cancer death cases in all 50 states.
Free Januvia Death Lawsuit Evaluation: If your loved one died from thyroid cancer or pancreatic cancer after taking Januvia, you should contact our law firm immediately. You may be entitled to compensation by filing a Januvia death suit and we can help.